BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Schütte K, Schulz C, Link A, Malfertheiner P. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. World J Hepatol 2015; 7(2): 139-149 [PMID: 25729470 DOI: 10.4254/wjh.v7.i2.139]
URL: https://www.wjgnet.com/1948-5182/full/v7/i2/139.htm
Number Citing Articles
1
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
2
Andrea Martini, Andrea Gallotta, Patrizia Pontisso, Giorgio Fassina. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis CWorld Journal of Hepatology 2015; 7(29): 2913-2919 doi: 10.4254/wjh.v7.i29.2913
3
Valérie Vilgrain, Bernard E. Van Beers, Catherine M. Pastor. Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRIJournal of Hepatology 2016; 64(3): 708 doi: 10.1016/j.jhep.2015.11.016
4
Weiyi Wang, Chao Wei. Advances in the early diagnosis of hepatocellular carcinomaGenes & Diseases 2020; 7(3): 308 doi: 10.1016/j.gendis.2020.01.014
5
Nergis Ekmen, Çağri Akalin, Murat Akyildiz. Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidatesEuropean Journal of Gastroenterology & Hepatology 2021; 32(2): 294 doi: 10.1097/MEG.0000000000001884
6
Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(37): 10584-10597 doi: 10.3748/wjg.v21.i37.10584
7
Chalermchai Pilapong, Sangsirin Siriwongnanon, Yanee Keereeta. Development of targeted multimodal imaging agent in ionizing radiation-free approach for visualizing hepatocellular carcinoma cellsSensors and Actuators B: Chemical 2017; 245: 683 doi: 10.1016/j.snb.2017.02.012
8
Atieh Pourbagheri‐Sigaroodi, Fatemeh Fallah, Davood Bashash, Abdollah Karimi. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3913
9
Francesca Angileri, Geneviève Morrow, Jean-Yves Scoazec, Nicolas Gadot, Vincent Roy, Suli Huang, Tangchun Wu, Robert M. Tanguay. Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1Scientific Reports 2016; 6(1) doi: 10.1038/srep27464
10
Yu-Cheng Zhang, Zhuo Xu, Tian-Fu Zhang, Ya-Li Wang. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(34): 9853-9862 doi: 10.3748/wjg.v21.i34.9853
11
Ioannis A. Ziogas, Georgios Sioutas, Konstantinos S. Mylonas, Georgios Tsoulfas. Role of MicroRNA in the Diagnosis and Management of Hepatocellular CarcinomaMicroRNA 2019; 9(1): 25 doi: 10.2174/2211536608666190619155406
12
Qiuyue Hu, Shen Shen, Jianhao Li, Liwen Liu, Xin Liu, Yingying Zhang, Yongjian Zhou, Weiwei Zhu, Yan Yu, Guangying Cui. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular CarcinomaDisease Markers 2020; 2020: 1 doi: 10.1155/2020/3231273
13
Susanne Zweerink, Senait Mesghenna, Vera Mueck, Sigrid Schulte, Fabian Kuetting, Alexander Quaas, Tobias Goeser, Dirk Nierhoff. First evaluation of Neighbor of Punc E11 (NOPE) as a novel marker in human hepatocellular carcinomaCancer Biomarkers 2021; 30(1): 75 doi: 10.3233/CBM-190819
14
Xiao-Pin Ma, Guopeng Yu, Xubo Chen, Qianyi Xiao, Zhuqing Shi, Lu-Yao Zhang, Haitao Chen, Pengyin Zhang, Dong-Lin Ding, Hui-Xing Huang, Hexige Saiyin, Tao-Yang Chen, Pei-Xin Lu, Neng-Jin Wang, Hongjie Yu, Carly Conran, Jielin Sun, S. Lilly Zheng, Jianfeng Xu, Long Yu, De-Ke Jiang. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinomaTumor Biology 2016; 37(7): 9931 doi: 10.1007/s13277-016-4897-1
15
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and TreatmentBiosensors 2022; 12(5): 342 doi: 10.3390/bios12050342
16
Ilvira M. Khan, Donjeta Gjuka, Jingjing Jiao, Xiaoling Song, Ying Wang, Jing Wang, Peng Wei, Hashem B. El-Serag, Jorge A. Marrero, Laura Beretta. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with CirrhosisCancer Prevention Research 2021; 14(6): 667 doi: 10.1158/1940-6207.CAPR-20-0600
17
Yi Zhu, Jiang Zhu, Cong Lu, Qiushi Zhang, Wei Xie, Ping Sun, Xiaochuan Dong, Liang Yue, Yaoting Sun, Xiao Yi, Tiansheng Zhu, Guan Ruan, Ruedi Aebersold, Shi'ang Huang, Tiannan Guo. Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues Using PCT–SWATHPROTEOMICS – Clinical Applications 2019; 13(1) doi: 10.1002/prca.201700179
18
Pei-Pei Song, Ju-Feng Xia, Yoshinori Inagaki, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo, Wei Tang. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(1): 262-274 doi: 10.3748/wjg.v22.i1.262
19
Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, Barbara Stefanska. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma developmentEpigenetics 2018; 13(6): 605 doi: 10.1080/15592294.2018.1481706
20
Stefano Mazza, Chiara Frigerio, Daniele Alfieri, Aurelio Mauro, Francesca Torello Viera, Davide Scalvini, Chiara Barteselli, Carmelo Sgarlata, Letizia Veronese, Marco Bardone, Laura Rovedatti, Simona Agazzi, Elena Strada, Lodovica Pozzi, Marcello Maestri, Valentina Ravetta, Andrea Anderloni. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative TreatmentMedicina 2024; 60(5): 692 doi: 10.3390/medicina60050692
21
Dhandhukiya Manavkumar Kanubhai, Saiyed Musaratafrin Sabirali. Hepatocellular Carcinoma: A ReviewAsian Journal of Research in Pharmaceutical Sciences 2023; : 171 doi: 10.52711/2231-5659.2023.00030
22
Yu-Gui Zhang, Jiang-Tao Niu, Hong-Wei Wu, Xin-Lei Si, Shu-Juan Zhang, Dong-Hui Li, Tian-Tian Bian, Yue-Feng Li, Xing-Ke Yan, Matthias B. Stope. Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and TherapyAnalytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6692811
23
Tong Wu, Na Li, Fengyuan Luo, Zhihong Chen, Liyuan Ma, Tao Hu, Guini Hong, Hongdong Li. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairsBMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05299-9
24
Francesco Bellissimo, Marilia Rita Pinzone, Bruno Cacopardo, Giuseppe Nunnari. Diagnostic and therapeutic management of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12003-12021 doi: 10.3748/wjg.v21.i42.12003
25
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, Rohan Chaminda Siriwardana, Kamani Hemamala Tennekoon, Madunil Anuk Niriella, Sumadee De Silva. Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicityEgyptian Journal of Medical Human Genetics 2023; 24(1) doi: 10.1186/s43042-023-00433-x
26
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Keigo Saito, Yasushi Uemura, Tetsuya Nakatsura. Biomarkers for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(37): 10573-10583 doi: 10.3748/wjg.v21.i37.10573
27
Grace T. Kwok, Jing Ting Zhao, Jocelyn Weiss, Nancy Mugridge, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Bruce G. Robinson, Stan B. Sidhu. Translational applications of microRNAs in cancer, and therapeutic implicationsNon-coding RNA Research 2017; 2(3-4): 143 doi: 10.1016/j.ncrna.2017.12.002
28
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic indexBritish Journal of Biomedical Science 2021; 78(1): 18 doi: 10.1080/09674845.2020.1778842
29
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosisArab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
30
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio. Advancements in the Diagnosis of Hepatocellular CarcinomaInternational Journal of Translational Medicine 2023; 3(1): 51 doi: 10.3390/ijtm3010005
31
Vaneet Jearth, Prachi S. Patil, Shaesta Mehta, Sridhar Sundaram, Vishal Seth, Mahesh Goel, Shraddha Patkar, Munita Bal, Vidya Rao. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not BrokenJournal of Clinical and Experimental Hepatology 2022; 12(3): 841 doi: 10.1016/j.jceh.2021.11.006
32
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosisWorld Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
33
Chao Ye, Xiaoqian Zhang, Xinyu Chen, Qingyi Cao, Xiaobing Zhang, Yanwen Zhou, Wenxin Li, Liangjie Hong, Haiyang Xie, Xiaoli Liu, Hongcui Cao, Ying-Jie Wang, Bo Kang. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4Cellular Oncology 2020; 43(2): 279 doi: 10.1007/s13402-019-00487-3
34
A. Biasiolo, A. Martini, A. Gallotta, G. Fassina, P. Pontisso. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 559 doi: 10.1007/978-94-007-7675-3_15
35
Yiyu Lu, Zhaoyuan Fang, Meiyi Li, Qian Chen, Tao Zeng, Lina Lu, Qilong Chen, Hui Zhang, Qianmei Zhou, Yan Sun, Xuefeng Xue, Yiyang Hu, Luonan Chen, Shibing Su, Jiarui Wu. Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testingJournal of Molecular Cell Biology 2019; 11(8): 665 doi: 10.1093/jmcb/mjz025
36
Jiatao Lou, LingFei Zhang, Shaogang Lv, Chenzi Zhang, Shuai Jiang. Biomarkers for Hepatocellular CarcinomaBiomarkers in Cancer 2017; 9: 1179299X1668464 doi: 10.1177/1179299X16684640
37
Maissa El Raziky, Hanan Abdel Hafez, Aisha Elsharkawy, Tarek Ahmed Moneer, Suzan M. EL-Sheikh, Rabab M. Maher, Sahar A. Sharaf. Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinomaEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00125-4
38
Fei Li, Ting Liu, Chun-Yang Xiao, Jing-Xia Yu, Lun-Gen Lu, Ming-Yi Xu. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infectionBiomedicine & Pharmacotherapy 2015; 72: 103 doi: 10.1016/j.biopha.2015.04.006
39
A. Biasiolo, A. Martini, A. Gallotta, G. Fassina, P. Pontisso. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_15-1
40
Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinomaGenes & Diseases 2017; 4(2): 116 doi: 10.1016/j.gendis.2017.03.003
41
Kashif Rafiq Zahid, Shiming Han, Fuling Zhou, Umar Raza. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell deathCellular Oncology 2019; 42(1): 55 doi: 10.1007/s13402-018-0407-3
42
Jia H. Koh, Meng Wang, Hiroyuki Suzuki, Mark Muthiah, Cheng H. Ng, Daniel Q. Huang. NAFLD and NAFLD-related HCC in Asia: Burden and SurveillanceJournal of Clinical and Experimental Hepatology 2024; 14(1): 101213 doi: 10.1016/j.jceh.2023.06.013
43
Shicai Fan, Jianxiong Tang, Qi Tian, Chunguo Wu. A robust fuzzy rule based integrative feature selection strategy for gene expression data in TCGABMC Medical Genomics 2019; 12(S1) doi: 10.1186/s12920-018-0451-x
44
Martin Franck, Kerstin Schütte, Peter Malfertheiner, Alexander Link. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factorsWorld Journal of Gastroenterology 2020; 26(1): 86-96 doi: 10.3748/wjg.v26.i1.86
45
Nicole Golob-Schwarzl, Sonja Kessler, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 22017; : 119 doi: 10.1007/978-3-319-53661-3_6
46
Olfat Al-Harazi, Ibrahim H. Kaya, Maha Al-Eid, Lina Alfantoukh, Ali Saeed Al Zahrani, Mohammed Al Sebayel, Namik Kaya, Dilek Colak. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network AnalysesFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.710049
47
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysisScandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824
48
Sania Safdar Butt, Khushbukhat Khan, Yasmin Badshah, Mehak Rafiq, Maria Shabbir. Evaluation of pro-apoptotic potential of taxifolin against liver cancerPeerJ 2021; 9: e11276 doi: 10.7717/peerj.11276
49
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silicoFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
50
Patrick Pham, Voreak Suybeng, Mohamed Takka, Nelly Bosselut, Rodolphe Sobesky, Jocelyne Hamelin, Didier Samuel, Raphaël Saffroy, Antoinette Lemoine. Cirrhose et carcinome hépatocellulaire : diagnostic et suivi biologiqueRevue Francophone des Laboratoires 2017; 2017(490): 64 doi: 10.1016/S1773-035X(17)30080-1
51
Niveditta Ramkumar, Jeffrey P. Jacobs, Richard B. Berman, Devin M. Parker, Todd A. MacKenzie, Donald S. Likosky, Anthony DiScipio, David J. Malenka, Jeremiah R. Brown. Cardiac Biomarkers Predict Long-term Survival After Cardiac SurgeryThe Annals of Thoracic Surgery 2019; 108(6): 1776 doi: 10.1016/j.athoracsur.2019.04.123
52
Da Kim, Eun Cho, Kyung-Sang Yu, In-Jin Jang, Jung-Hwan Yoon, Taesung Park, Joo-Youn Cho. Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from CirrhosisCancers 2019; 11(10): 1497 doi: 10.3390/cancers11101497
53
Wen Li, Ruosha Li, Qingxiang Yan, Ziding Feng, Jing Ning. Conditional concordance‐assisted learning under matched case‐control design for combining biomarkers for population screeningStatistics in Medicine 2023; 42(9): 1398 doi: 10.1002/sim.9677